EXPEDITED REVIEW
Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation
Peter B. Sick, MD*,*,
Gerhard Schuler, MD ,
Karl Eugen Hauptmann, MD ,
Eberhard Grube, MD, FACC ,
Steve Yakubov, MD, FACC||,
Zoltan G. Turi, MD, FACC¶,
Gregory Mishkel, MD, FACC#,
Steve Almany, MD, FACC** and
David R. Holmes, MD, FACC
* Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
University of Leipzig, Heart Center GmbH, Leipzig, Germany
Krankenhaus der Barmherzigen Brüder, Trier, Germany
Heart Center Siegburg, Siegburg, Germany
|| Midwest Cardiology Research Foundation, Riverside Methodist Hospital, Columbus, Ohio
¶ Cooper Hospital, Camden, New Jersey
# Prairie Education and Research, Springfield, Illinois
** William Beaumont Hospital, Cardiology Center, Royal Oak, Michigan
 Mayo Clinic, St. Marys Hospital, Rochester, Minnesota.
Manuscript received February 8, 2007;
revised manuscript received February 26, 2007,
accepted February 28, 2007.
* Reprint requests and correspondence: Dr. Peter B. Sick, Krankenhaus der Barmherzigen Brüder Regensburg, Medizinische Klinik III/Kardiologie, Prüfeningerstrasse 86, 93049 Regensburg, Germany. (Email: peter.sick{at}barmherzige-regensburg.de).
Objectives: This study assessed the feasibility of implanting a device in the left atrial appendage (LAA) in patients with atrial fibrillation (AF) to prevent thromboembolic stroke.
Background: Meta-analyses confirmed that in cases of left atrial thrombus in nonrheumatic AF patients approximately 90% of them are in the LAA.
Methods: The WATCHMAN Left Atrial Appendage System (Atritech Inc., Plymouth, Minnesota) is a nitinol device implanted percutaneously to seal the LAA. Patients were followed by clinical and transesophageal echocardiography at 45 days and 6 months with annual clinical follow-up thereafter.
Results: Sixty-six patients underwent device implantation. Mean follow-up was 740 ± 341 days. At 45 days, 93% (54 of 58) devices showed successful sealing of LAA according to protocol. Two patients experienced device embolization, both successfully retrieved percutaneously. No embolizations occurred in 53 patients enrolled after modification of fixation barbs. There were 2 cardiac tamponades, 1 air embolism, and 1 delivery wire fracture (first generation) with surgical explantation but no long-term sequelae for the patient. Four patients developed a flat thrombus layer on the device at 6 months that resolved with additional anticoagulation. Two patients experienced transient ischemic attack, 1 without visible thrombus. There were 2 deaths, neither device related. Autopsy documented a stable, fully endothelialized device 9 months after implantation. No strokes occurred during follow-up despite >90% of patients with discontinuation of anticoagulation.
Conclusions: Preliminary data suggest LAA occlusion with the WATCHMAN System to be safe and feasible. A randomized study is ongoing comparing oral anticoagulation with percutaneous closure.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | LAA = left atrial appendage | | TEE = transesophageal echocardiography | | TIA = transitory ischemic attack |
|
Related Article
-
Watching the Watchman
- Peter C. Block
J. Am. Coll. Cardiol. 2007 49: 1496-1497.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. Michael Gray, M. Nagendran, and M. Maruthappu
Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
Interact CardioVasc Thorac Surg,
December 1, 2011;
13(6):
642 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Landmesser and D. R. Holmes Jr
Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation
Eur. Heart J.,
October 31, 2011;
(2011)
ehr393v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Chue, J. de Giovanni, and R. P. Steeds
The role of echocardiography in percutaneous left atrial appendage occlusion
Eur Heart J Cardiovasc Imaging,
October 1, 2011;
12(10):
i3 - i10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Blume, C. J. Mcleod, M. E. Barnes, J. B. Seward, P. A. Pellikka, P. M. Bastiansen, and T. S. M. Tsang
Left atrial function: physiology, assessment, and clinical implications
Eur Heart J Cardiovasc Imaging,
June 1, 2011;
12(6):
421 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Jain and S. Gallagher
Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance
Heart,
May 1, 2011;
97(9):
762 - 765.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Y. Reddy, D. Holmes, S. K. Doshi, P. Neuzil, and S. Kar
Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry
Circulation,
February 1, 2011;
123(4):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Salzberg and H. Tolboom
Management of the left atrial appendage
MMCTS,
January 1, 2011;
2011(1118):
mmcts.2010.004432 - mmcts.2010.004432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. McLeod and B. J. Gersh
A practical approach to the management of patients with atrial fibrillation
Heart Asia,
September 6, 2010;
2(1):
95 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Delgado, F. van der Kley, M. J. Schalij, and J. J. Bax
Optimal imaging for planning and guiding interventions in structural heart disease: a multi-modality imaging approach
Eur. Heart J. Suppl.,
September 1, 2010;
12(suppl_E):
E10 - E23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Khattab and B. Meier
Transcatheter left atrial appendage exclusion, gold or fool's gold?
Eur. Heart J. Suppl.,
September 1, 2010;
12(suppl_E):
E35 - E40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Marcus, M. M. Scheinman, and E. Keung
The Year in Clinical Cardiac Electrophysiology
J. Am. Coll. Cardiol.,
August 17, 2010;
56(8):
667 - 676.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Schwartz, D. R. Holmes, R. A. Van Tassel, R. Hauser, T. D. Henry, M. Mooney, R. Matthews, S. Doshi, R. M. Jones, and R. Virmani
Left Atrial Appendage Obliteration: Mechanisms of Healing and Intracardiac Integration
J. Am. Coll. Cardiol. Intv.,
August 1, 2010;
3(8):
870 - 877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Cox
The longstanding, persistent confusion surrounding surgery for atrial fibrillation
J. Thorac. Cardiovasc. Surg.,
June 1, 2010;
139(6):
1374 - 1386.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Dawson, S. Asopa, and J. Dunning
Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?
Interact CardioVasc Thorac Surg,
February 1, 2010;
10(2):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Holmes Jr and R. S. Schwartz
Left Atrial Appendage Occlusion Eliminates the Need for Warfarin
Circulation,
November 10, 2009;
120(19):
1919 - 1926.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Holmes Jr, R. Nishimura, R. Fountain, and Z. G. Turi
Iatrogenic Pericardial Effusion and Tamponade in the Percutaneous Intracardiac Intervention Era
J. Am. Coll. Cardiol. Intv.,
August 1, 2009;
2(8):
705 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. L Bayard, S. H Ostermayer, and H. Sievert
Alternatives to warfarin in atrial fibrillation: drugs and devices
Heart,
September 1, 2008;
94(9):
1113 - 1116.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2355 - 2369.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Koebe and P. Kirchhof
Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation
Europace,
April 1, 2008;
10(4):
433 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stollberger and J. Finsterer
WATCHMAN for Stroke Prevention: An Out-of-Date Procedure
J. Am. Coll. Cardiol.,
August 28, 2007;
50(9):
914 - 914.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sick
Reply
J. Am. Coll. Cardiol.,
August 28, 2007;
50(9):
914 - 915.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Block
Watching the Watchman
J. Am. Coll. Cardiol.,
April 3, 2007;
49(13):
1496 - 1497.
[Full Text]
[PDF]
|
 |
|
|